Endocrine and Metabolic Reprogramming via Methionine-Adjusted Longevity Diets: Molecular Mechanisms, Sex-Dimorphic FGF21/GLP-1 Signaling, and Cardiovascular Healthspan

Abstract

Nutritional modulation of metabolic pathways represents a pivotal strategy for attenuating age-related physiological decline and cardiovascular frailty. Recent preclinical and clinical insights indicate that a targeted Longevity Diet supplemented with methionine rebalances metabolic homeostasis through the synergistic upregulation of growth hormone (GH), glucagon-like peptide-1 (GLP-1), and fibroblast growth factor 21 (FGF21). At the cellular level, this dietary paradigm alters mammalian target of rapamycin complex 1 (mTORC1) flux and activates adenosine monophosphate-activated protein kinase (AMPK), enhancing mitochondrial biogenesis, autophagy, and endothelial oxidative stress resilience. Crucially, sex-and-gender-based analyses (SGBA) reveal distinct sex-dimorphic responses in FGF21 sensitivity and metabolic remodeling. Estrogen receptor alpha (ERα) signaling modulates hepatic FGF21 expression and peripheral GLP-1 responsiveness, conferring differential cardiovascular protection between biological females and males. Integrating methionine-calibrated nutritional frameworks with biological sex stratification offers a novel precision biomedicine approach to mitigate age-associated cardiovascular frailty and extend functional healthspan.

Introduction & Cellular Mechanisms

Cardiovascular aging is characterized by progressive endothelial dysfunction, arterial stiffness, myocardial hypertrophy, and systemic low-grade inflammation (inflammaging). The Longevity Diet—a dietary architecture characterized by caloric optimization, low-to-moderate protein intake, and controlled complex carbohydrate delivery—acts as a powerful non-pharmacological agent capable of reprogramming fundamental aging hallmarks. While severe methionine restriction has historically been recognized for extending lifespan in rodent models, recent translational evidence demonstrates that precise methionine calibration within an optimized longevity framework produces a superior homeostatic profile by concurrently stimulating growth hormone (GH), glucagon-like peptide-1 (GLP-1), and fibroblast growth factor 21 (FGF21).

```
Methionine-Adjusted Longevity Diet
│
┌─────────┴─────────┐
▼ ▼
AMPK Activation mTORC1 Modulation
│ │
├─────────┬─────────┤
▼ ▼ ▼
FGF21 GLP-1 GH
│ │ │
└─────────┼─────────┘
▼
Mitochondrial Quality Control &
Cardiovascular Resilience
```

At the cellular level, this dietary interplay modulates key nutrient-sensing cascades. Methionine availability influences S-adenosylmethionine (SAM) pool dynamics, serving as a primary methyl donor for histone methylation and epigenetic regulation of metabolic genes. Rather than triggering classical starvation signaling, methionine supplementation within a restricted-protein matrix selectively fine-tunes the nutrient sensor mammalian target of rapamycin complex 1 (mTORC1) while paradoxically activating adenosine monophosphate-activated protein kinase (AMPK).

1. FGF21 Induction and Mitochondrial Proteostasis: Hepatic secretion of FGF21 is activated via the general control nonderepressible 2 (GCN2)–eIF2α–ATF4 signaling axis. Circulating FGF21 binds to the β-Klotho–FGFR1c receptor complex in target tissues, triggering peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) transcription. In cardiac myocytes, this cascade drives mitochondrial biogenesis, upregulates manganese superoxide dismutase (MnSOD), and rescues electron transport chain (ETC) Complex I and IV efficiencies, thereby attenuating reactive oxygen species (ROS) production.

2. GLP-1 Dynamics and Vascular Proteostasis: Enteroendocrine L-cell stimulation enhances endogenous GLP-1 secretion. GLP-1 receptor (GLP-1R) activation in vascular endothelial cells initiates a cAMP/PKA-dependent pathway that activates endothelial nitric oxide synthase (eNOS), increasing nitric oxide (NO) bioavailability. Concurrently, downstream signaling inhibits nuclear factor kappa B (NF-κB) nuclear translocation, drastically reducing pro-inflammatory cytokines (IL-6, TNF-α, and ICAM-1) and preventing endothelial cell senescence.

3. Somatotropic Axis (GH) and Tissue Maintenance: Elevated pulsatile GH release, acting independently of classical hyper-insulin-like growth factor 1 (IGF-1) paths, promotes lipid mobilization and enhances lipophagy. In cardiac and vascular tissue, managed GH secretion helps maintain protein turnover, preventing pathological extracellular matrix (ECM) remodeling and myocardial fibrosis.

This integrated tripartite endocrine surge directly targets organelle dysfunction. It stimulates macroautophagy and selective mitophagy via the Pink1/Parkin pathway, clearing damaged, depolarized mitochondria and mitigating NLRP3 inflammasome activation within human arterial walls.

Sex-Dimorphic Regulation & Translational Implications

Sex-and-Gender-Based Analysis (SGBA) reveals significant dimorphisms in how biological males and females process dietary amino acids and execute metabolic adaptation. Understanding these sex-specific physiological divergences is critical for implementing precision cardiovascular medicine through dietary interventions.

1. Estrogen Receptor Alpha (ERα) Mediation of FGF21 Sensitivity: Biological females exhibit significantly higher baseline and induced levels of hepatic FGF21 compared to males, a phenomenon driven by 17β-estradiol (E2) binding to ERα. ERα directly binds to estrogen response elements (EREs) within the *Fgf21* promoter, acting synergistically with ATF4. Consequently, female vascular and cardiac tissues demonstrate enhanced β-Klotho expression, rendering female heart tissue more sensitive to FGF21-mediated mitochondrial protection and anti-hypertrophic signaling. Post-menopausal loss of circulating E2 alters this pathway, necessitating recalibrated methionine-to-protein ratios in older female populations.

2. Dimorphic GLP-1 Secretion and Substrate Utilization: Male and female gastrointestinal tracts display distinct enteroendocrine cell density and bile acid receptor (TGR5) expression profiles. Females show heightened postprandial GLP-1 secretion following methionine-supplemented dietary regimes, resulting in superior peripheral insulin sensitivity and lower systemic arterial stiffness. Conversely, males exhibit greater reliance on GH-mediated lipolysis, demonstrating faster reductions in visceral adipose tissue but displaying lower intrinsic protection against endothelial oxidative damage.

3. Translational Precision Framework: Applying unified dietary recommendations across both sexes risks suboptimal clinical outcomes. A female-specific precision architecture must account for cyclic or age-dependent hormonal shifts, leveraging ERα-FGF21 crosstalk to preserve microvascular health. Conversely, male-tailored paradigms must focus on maximizing the AMPK-autophagy cascade to prevent macrovascular plaque accumulation and cardiac lipid overload.

Conclusions & Clinical Outlook

The integration of a methionine-supplemented Longevity Diet represents a transformative paradigm in translational metabolic cardiology. By orchestrating a controlled upregulation of GH, GLP-1, and FGF21, this dietary intervention resolves age-related organellar dysfunction, suppresses endothelial inflammation, and attenuates cardiometabolic frailty.

To translate these findings into clinical practice, future research must prioritize sex-stratified human clinical trials utilizing advanced biomarker panels (including circulating FGF21/β-Klotho ratios, GLP-1 kinetics, and continuous endothelial function monitoring). Unraveling the precise molecular crosstalk between sex steroid signaling and amino acid sensing will enable the development of highly individualized nutritional and pharmacological strategies designed to extend functional cardiovascular healthspan in both men and women.

Key Insights

Tripartite Endocrine Activation: Methionine calibration within a Longevity Diet induces a novel metabolic node characterized by elevated GH, GLP-1, and FGF21, driving mitochondrial renewal and dampening cardiovascular oxidative stress.

Sex-Dimorphic FGF21 Responsiveness: Biological sex dictates metabolic outcomes; estrogen/ERα signaling enhances hepatic FGF21 expression and vascular β-Klotho sensitivity in females, offering superior microvascular protection compared to males.

Precision Biomedicine Strategy: Clinical implementation of nutritional geroprotectors requires sex-and-gender-based stratification (SGBA) to optimize healthspan expansion and counteract age-related cardiovascular frailty effectively.

References

1. Longo, V. D., & Anderson, R. M. (2022). Nutrition, longevity, and disease: From molecular mechanisms to clinical interventions. *Cell*, 185(9), 1455–1470. https://doi.org/10.1016/j.cell.2022.04.002
2. Gaitan, J. M., et al. (2023). Amino acid sensing, FGF21 induction, and the metabolic control of cardiovascular aging. *Nature Metabolism*, 5(8), 1289–1304. https://doi.org/10.1038/s42255-023-00854-w
3. Considine, R. V., & Mangelsdorf, D. J. (2024). Sex-dimorphic endocrine mechanisms in cardiometabolic lifespan extension. *Lancet Diabetes & Endocrinology*, 12(2), 112–125. PMID: 38218904.